MetaStat, Inc. (MTST)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
At close: Jun 3, 2025
100.00%
Market Cap 1.18K
Revenue (ttm) 23.30K
Net Income (ttm) -3.31M
Shares Out 5.88M
EPS (ttm) -0.61
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 95,168
Average Volume 36,011
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0002
52-Week Range 0.0001 - 0.0030
Beta 12.83
RSI 44.32
Earnings Date n/a

About MetaStat

MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid bl... [Read more]

Industry Biotechnology
Sector Healthcare
Employees 6
Stock Exchange OTCMKTS
Ticker Symbol MTST
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.